Expression and Clinical Significance of ILF2 in Gastric Cancer

<div>Kaplan-Meier survival analysis and log-rank test for OS and DFS of GC patients. The OS of GC patients with ILF2 high expression and low expression (a). The DFS of GC patients with ILF2 high expression and low expression (b).</div>

Disease Markers

fig5

Figure 5

Figure 5: Expression and Clinical Significance of ILF2 in Gastric Cancer 